Paula J. Lum

Hepatitis C Virus Reinfection Among People Who Inject Drugs

Patient-centred models of hepatitis C treatment for people who inject drugs: a multicentre, pragmatic randomised trial

Meeting people where they are: implementing hospital-based substance use harm reduction

HIV clinic‐based extended‐release naltrexone versus treatment as usual for people with HIV and opioid use disorder: a non‐blinded, randomized non‐inferiority trial

Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV Infection

Associations between fentanyl use and initiation, persistence, and retention on medications for opioid use disorder among people living with uncontrolled HIV disease

Computer-Facilitated 5A’s for Smoking Cessation: A Randomized Trial of Technology to Promote Provider Adherence

2017 HIVMA of IDSA Clinical Practice Guideline for the Management of Chronic Pain in Patients Living With HIV

Feasibility and safety of extended‐release naltrexone treatment of opioid and alcohol use disorder in HIV clinics: a pilot/feasibility randomized trial

2017 HIV Medicine Association of Infectious Diseases Society of America Clinical Practice Guideline for the Management of Chronic Pain in Patients Living With Human Immunodeficiency Virus

A Longitudinal Study of Multiple Drug Use and Overdose Among Young People Who Inject Drugs

Beyond the Ask and Advise: Implementation of a Computer Tablet Intervention to Enhance Provider Adherence to the 5As for Smoking Cessation

Association of Opioid Agonist Therapy With Lower Incidence of Hepatitis C Virus Infection in Young Adult Injection Drug Users

Higher risk of incident hepatitis C virus among young women who inject drugs compared with young men in association with sexual relationships: a prospective analysis from the UFO Study cohort

Mortality Among Young Injection Drug Users in San Francisco: A 10-Year Follow-up of the UFO Study

Smoking cessation interventions with female smokers living with HIV/AIDS: A randomized pilot study of motivational interviewing